Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Indications and Outcomes of Endoscopic Ultrasound in Tanta

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03267355
Recruitment Status : Unknown
Verified August 2017 by Tanta University.
Recruitment status was:  Recruiting
First Posted : August 30, 2017
Last Update Posted : August 30, 2017
Sponsor:
Information provided by (Responsible Party):
Tanta University

Brief Summary:
The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.

Condition or disease Intervention/treatment Phase
Gastric Disease Intestinal Disease Pancreatic Diseases Esophageal Diseases Device: Endoscopic Ultrasound Not Applicable

Detailed Description:
Detection of main causes for referral to EUS in Tanta, Egypt.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Indications and Outcomes of Gastrointestinal Endoscopic Ultrasound in Tanta-Egypt: Initial Experience.
Actual Study Start Date : January 2016
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy Ultrasound

Arm Intervention/treatment
Experimental: Gastrointestinal diseases
Endoscopic Ultrasound
Device: Endoscopic Ultrasound
Indication of EUS
Other Name: EUS




Primary Outcome Measures :
  1. Number of different indications for Endoscopic Ultrasound in Tanta, Egypt [ Time Frame: 10 months ]
    Evaluation of the initial experience of the indications and outcomes of GIT EUS



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All cases of gastrointestinal EUS

Exclusion Criteria:

  • Missed data

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03267355


Contacts
Layout table for location contacts
Contact: Sherief Abd-Elsalam, Ph D 00201095159522 Sheriefabdelsalam@yahoo.com

Locations
Layout table for location information
Egypt
Tanta university hospital Recruiting
Cairo, Egypt
Contact: Sherief Abd-Elsalam    00201000040794    Sherif_tropical@yahoo.com   
Sponsors and Collaborators
Tanta University
Investigators
Layout table for investigator information
Principal Investigator: Asem Elfert, Professor Tanta University Faculty of Medicine
Principal Investigator: Ferial El-kalla, Professor Tanta university Faculty of Medicine
Study Director: Samah Mosaad, consultant Tanta University Faculty of Medicine
Study Director: Walaa Elkhalawany, Consultant Tanta University Faculty of Medicine
Study Chair: Reham Elkhouly, Consultant Tanta University Faculty of Medicine
Study Chair: Eslam Saber, Specialist Tanta University Faculty of medicine
Layout table for additonal information
Responsible Party: Tanta University
ClinicalTrials.gov Identifier: NCT03267355    
Other Study ID Numbers: EUS TANTA
First Posted: August 30, 2017    Key Record Dates
Last Update Posted: August 30, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pancreatic Diseases
Intestinal Diseases
Esophageal Diseases
Stomach Diseases
Digestive System Diseases
Gastrointestinal Diseases